[1]苏莉,刘永民,刘永红,等.新型冠状病毒肺炎眼传播及其防控探讨[J].西部中医药,2020,33(S1):80.
 SU Li,LIU Yongmin,LIU Yonghong,et al.On Eye Transmission, the Prevention and Control of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):80.
点击复制

新型冠状病毒肺炎眼传播及其防控探讨()
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
33
期数:
2020年S1
页码:
80
栏目:
疫病·新冠肺炎
出版日期:
2021-06-30

文章信息/Info

Title:
On Eye Transmission, the Prevention and Control of COVID-19
作者:
苏莉刘永民刘永红王亦山柳青白蕾琪
甘肃省中医院眼科,甘肃 兰州 730050
Author(s):
SU Li LIU Yongmin LIU Yonghong WANG Yishan LIU Qing BAI Leiqi
Ophthalmology Department, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
关键词:
新型冠状病毒肺炎新型冠状病毒感染眼传播合理措施
Keywords:
COVID-19 SARS-CoV-2 infection eye transmission rational measures the epidemiology
分类号:
R197
文献标志码:
A
摘要:
通过中西医对新型冠状病毒肺炎的认识及文献复习,探讨新型冠状病毒经眼传播的可能机制,以及预防和治疗的合理措施。
Abstract:
The potential mechanism of SARS-CoV-2 transmitting via eye, rational measures of the prevention and treatment are discussed through the understanding to the disease from integrative medicine and literature review

参考文献/References:

[1] LU C W,LIU X F,JIA Z F.2019-n CoV transmission through the ocular surface must not be ignored[J].The Lancet,2020,395(10224):537-658.
[2] JIANHUA XIA M M,JIANPING TONG M D,MENGYUN LIU M M,et al.Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection[J].Journal of Medical Virology,2020,92(6):589-594.
[3] 李雪杰,汪明,陈长征,等.伴发或首发病毒性结膜炎的新型冠状病毒感染下眼科医师的防控策略[J].中华实验眼科杂志,2020,38(3):276-280.
[4] ZHOU P,YANG X L,WANG X G,et al.Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin[J/OL].bioRxiv,2020:1-18(2020-01-23)[2020-03-09].https://
www.biorxiv.org/content/10.1101/2020.01.22.914952v2.
[5] 郭丽,王建伟,洪涛.冠状病毒分子生物学研究进展[J].病毒学报,2003,19(4):376-380.
[6] 马亦林.冠状病毒的特性及其致病性研究进展[J].中华临床感染病杂志,2018,11(4):305-315.
[7] LAM T T Y,HU Y L,GUAN Y,et al.Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China[J/OL].bioRxiv,2020:1-22(2020-02-18)[2020-03-09].https://www.biorxiv.org/content/10.1101/2020.02.13.945485v1.
[8] 国家卫生健康委员会办公厅,国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第六版)[J].中国病毒病杂志,2020,10(2):81-85.
[9] HOLSHUE M L,DeBOLT C,LINDQUIST S,et al.First Case of 2019 Novel coronavirus in the United States[J].N Engl J Med,2020,382:929-936.
[10] BELSER J A,ROTA P A,TUMPEY T M.Ocular tropism of respiratory viruses[J].Microbiol Mol Biol Rev,2013,77(1):144-156.
[11] CHENTOUFI A A,DASGUPTA G,NESBURN A B,et al.Nasolacrimal duct closure modulates ocular mucosal and systemic CD4+ T-cell responses induced following topical ocular or intranasal immunization[J].Clin Vaccine Immunol,2010,17(3):342-353.
[12] IMAI Y,KUBA K,OHTO-NAKANISHI T,et al.Angiotensinconverting enzyme 2(ACE2) in disease pathogenesis[J].Circ J,2010,74(3):405-410.
[13] Li W,Moore MJ,Vasilieva N,et al.Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus[J].Nature,2003,426(6965):450-454.
[14] LOON S C,TEOH S C B,OON L L E,et al.The severe acute respiratory syndrome coronavirus in tears[J].Br J phthalmol,2004,88(7):861-863.
[15] 马淮健,王宏伟,方立群,等.医务人员SARS感染的危险因素病例对照研究[J].中华流行病学杂志,2004,25(9):741-744.
[16] KANSKI J J,BOWLING B.临床眼科学[J].赵培泉,主译.7 版.北京:北京大学医学出版社,2015:132-147.
[17] 彭清华.中医眼科学[M].9版.北京:中国中医药出版社,2012:118-121.
[18] 张铭志.关注新型冠状病毒感染的肺炎(COVID-19)与眼表传播问题[J/OL].国际眼科杂志,2020:1-11(2020-02-23)[2020-03-09].http://kns.cnki.net/kcms/detail/61.1419.R.20200223.1432.002.html.

相似文献/References:

[1]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
 LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):1.
[2]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
 SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):3.
[3]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
 DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):5.
[4]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
 PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):7.
[5]王 雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(S1):11.
 Under the Impact of COVID-9 Epidemic.Reflection on the Diagnosis and Treatment of Orthopedic Diseases[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):11.
[6]杨海侠,张银萍△,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药,2020,33(S1):13.
[7]丁潇,邹忆怀△,辛大永,等.北京顺义地区新型冠状病毒肺炎的中医临床证候与CT表现[J].西部中医药,2020,33(S1):16.
 DING Xiao,ZOU Yihuai,XIN Dayong,et al.TCM Clinical Syndromes and CT Manifestations of COVID-19 in Shunyi District of Beijing[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):16.
[8]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
 SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):18.
[9]闫向勇,李 俊,燕忠生△.武汉地区新型冠状病毒肺炎中医证候及病机特点[J].西部中医药,2020,33(S1):20.
 YAN Xiangyong,LI Jun,YAN Zhongsheng.On the Characteristics of TCM Patterns and the Pathogenesis of COVID-19 in Wuhan Region[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):20.
[10]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
 and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]

备注/Memo

备注/Memo:
收稿日期:2020-03-29 作者简介:苏莉(1970—),女,主任医师。
更新日期/Last Update: 2020-08-14